Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational1 basis and ...
Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果